180 Life Sciences Corp.
Stock Forecast, Prediction & Price Target

180 Life Sciences Corp. Financial Estimates

180 Life Sciences Corp. Revenue Estimates

180 Life Sciences Corp. EBITDA Estimates

180 Life Sciences Corp. Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $16.64M
Low: $16.64M
High: $16.64M
avg. 0%
Avg: $30.41M
Low: $30.41M
High: $30.41M
avg. 82.74%
Net Income
 
% change YoY
$-20.32M
 
N/A
$-38.72M
 
-90.53%
$-19.93M
 
48.52%
Avg: $-21.60M
Low: $-21.60M
High: $-21.60M
avg. -8.39%
Avg: $21.60M
Low: $21.60M
High: $21.60M
avg. 200%
EBITDA
 
% change YoY
$-15.53M
 
N/A
$-17.78M
 
-14.53%
$-22.13M
 
-24.42%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$247.86
 
N/A
-$387.26
 
-56.24%
-$52.6
 
86.41%
Avg: -$57
Low: -$57
High: -$57
avg. -8.36%
Avg: $57
Low: $57
High: $57
avg. 200%
Operating Expenses
 
% change YoY
$20.16M
 
N/A
$39.64M
 
96.62%
$13.47M
 
-66.00%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is 180 Life Sciences Corp. stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 95.80% in 2025-2026.

We have gathered data from N/A analysts. Their low estimate is -21.60M, average is -21.60M and high is -21.60M.

What is 180 Life Sciences Corp. stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 41.37% in 2025-2026.

We have gathered data from 1 analysts. Their low revenue estimate is $16.64M, average is $16.64M and high is $16.64M.

What is 180 Life Sciences Corp. stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 95.81% in 2025-2026.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$57, average is -$57 and high is $-57.